TechFlow news — On September 25, the decentralized science (DeSci) project AminoChain announced a $5 million seed round led by a16z. This marks a16z's first investment in the DeSci space. AminoChain is building an L2 blockchain protocol connecting enterprise healthcare institutions and developing user-owned decentralized healthcare applications on top of it. Its first application is a biosample marketplace, where researchers can query and license samples through a biobank network. Patients can track how their samples are used, gain new insights, and receive revenue when their samples are sold. AminoChain aims to build a new enterprise-grade on-chain bioeconomy and plans to launch multiple decentralized applications in areas such as clinical recruitment, real-world evidence, and federated learning.
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / [email protected] ICP License: 琼ICP备2022009338号
